Susana Almeida, PhD
Secretary General, IGBA
Dr. Susana Almeida was nominated Secretary General of the International Generic and Biosimilar medicines Association (IGBA) in January 2024.
With over 20 years of substantial contribution to the role of the European and international generic and biosimilar medicines industry’s trade bodies and companies, Susana also brings significant experience in the process of international harmonisation of standards through the International Conference on Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).
Before joining the IGBA, Susana was Clinical Development and Safety Director at Medicines for Europe. She has also worked in clinical trials and pharmacovigilance in Europe and in North America, and her experience includes the pharmaceutical industry and clinical research organizations.
Susana is a firm believer that the generic and biosimilar medicines industries play a vital role in fostering worldwide patient access to quality-assured medicines and that a strong off patent sector is essential to a healthy medicines ecosystem
She holds a PhD in Clinical Pharmacology from the Faculty of Medicine, Universidad Autònoma de Barcelona (UAB), Spain (2011) and has authored several scientific papers and patents.